GARY HOLLANDER: Open Payments
NPI 1902896749 · WALLED LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 46 payments from 14 companies in 2025. Trend: 2023 $546 · 2024 $519 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $242 |
| Novo Nordisk Inc | 7 | $135 |
| RGH Enterprises LLC | 2 | $135 |
| PFIZER INC. | 5 | $98 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Amgen Inc. | 3 | $58 |
| Dexcom, Inc. | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 1 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Lilly USA, LLC | 3 | $46 |
Products named: BREZTRI, Wegovy, FARXIGA, Rybelsus, ELIQUIS, TRELEGY ELLIPTA, Dexcom G6 Transmitter, REBYOTA.
Industry payments across MI — which companies pay providers there.
